NAFDAC Prohibits Sale of Dex Luxury Bar Soap

The National Agency for Food and Drug Administration Control (NAFDAC) has banned the sale of Dex Luxury bar soap following the discovery of Butyphenyl Methylpropional (BMHCA) in the product. BMHCA, a substance prohibited in cosmetic products due to its potential adverse effects on the reproductive system and skin sensitization, was found in Dex Luxury Bar Soap (No 6 Mystic Flower), manufactured in Turkey.

In a statement posted on NAFDAC’s official channels on Thursday, the agency highlighted the product’s non-compliance with the Cosmetic Products Regulation, citing the presence of BMHCA as a significant concern. The substance poses risks such as harm to the reproductive system, potential health risks to unborn children, and skin sensitization, prompting regulatory action by both the European Union (EU) and other public authorities.

Despite the absence of Dex Luxury Bar Soap from the NAFDAC database, importers, distributors, retailers, and consumers are advised to exercise caution and vigilance within the supply chain to prevent the product’s importation, distribution, sale, and use. Healthcare professionals and consumers are urged to report any suspicions of adverse reactions or encounters with substandard or falsified regulated products to the nearest NAFDAC office for prompt action and further investigation.